Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-745
Closed -$244K 93
2025
Q4
$244K Buy
+745
New +$236K 0.07% 88
2025
Q2
Sell
-768
Closed -$239K 103
2025
Q1
$239K Buy
+768
New +$227K 0.1% 76
2019
Q2
Sell
-647
Closed -$123K 122
2019
Q1
$123K Hold
647
0.06% 115
2018
Q4
$126K Hold
647
0.07% 109
2018
Q3
$134K Hold
647
0.06% 103
2018
Q2
$119K Hold
647
0.06% 108
2018
Q1
$110K Sell
647
-161
-20% -$29.6K 0.05% 115
2017
Q4
$141K Buy
808
+170
+27% +$30.1K 0.06% 106
2017
Q3
$119K Sell
638
-91
-12% -$16.1K 0.06% 111
2017
Q2
$125K Buy
729
+147
+25% +$23.9K 0.06% 108
2017
Q1
$96K Sell
582
-2
-0.3% -$332 0.05% 122
2016
Q4
$85K Buy
+584
New +$87.9K 0.04% 133

Other funds holding AMGN

Omnia Family Wealth's AMGN Position: Q1 2026 in Review

Omnia Family Wealth sold out of Amgen (AMGN) in Q1 2026, closing a stake of 745 shares — an estimated $244K sold.

Omnia Family Wealth first reported a position in AMGN in Q4 2016 and held it in 12 quarters. The position peaked at $244K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Omnia Family Wealth reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Omnia Family Wealth sold 745 Amgen shares in Q1 2026, an estimated $244K.
  • Omnia Family Wealth first reported a position in Amgen in Q4 2016 and held it in 12 quarters.
  • Omnia Family Wealth's Amgen position peaked at $244K in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Omnia Family Wealth's 13F filing for Q1 2026, filed 7 May 2026.